Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM

Sathish Kumar, Anita D'Souza, MBBS, Emma C. Scott, MD, Raphael Fraser, Omar Davila, Cristina J. Gasparetto, MD, Shaji K Kumar, MD, Tomer M Mark, MDMSc, Yago Nieto, MD PhD, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 2024.

https://doi.org/10.1182/blood.V130.Suppl_1.2024.2024

Published: 2017

Journal Articles

A Comparison between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database

Emma Scott, Parameswaran Hari, MD MRCP, MS, Sathish Kumar, Raphael Fraser, Omar Davila, Yago Nieto, MD PhD, Tomer M Mark, MDMSc, Shaji K Kumar, MD, Cristina J. Gasparetto, MD, Anita D'Souza, MBBS

Blood (2017) 130 (Supplement 1): 3042.

https://doi.org/10.1182/blood.V130.Suppl_1.3042.3042

Published: 2017

Journal Articles

Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging

Cinnie Yentia Soekojo, MD MRCP, Guo-miao Wang, Yunxin Chen, Joshua Casan, Grace Wolyncewicz, Adeline Lin, LM Poon, Liang Piu Koh, Lip Kun Tan, Melissa Ooi, Yang Liu, Xiao-Jun Huang, MD, Andrew Spencer, MD, Sathish Kumar, Jin Lu, Wee Joo Chng, MB ChB, MRCP, PhD

Blood (2017) 130 (Supplement 1): 3119.

https://doi.org/10.1182/blood.V130.Suppl_1.3119.3119

Published: 2017

Journal Articles

Therapeutic Targeting of PIM Protein Kinases in a Subset of T-Cell Acute Lymphoblastic Leukemia

Sathish Kumar Reddy Padi, PhD, Libia A Luevano, ND, Ningfei An, PhD, Ritu Pandey, PhD, Neha Singh, PhD, Jin H Song, PhD, Jon C. Aster, MD PhD, Xue-Zhong Yu, PhD, Shikhar Mehrotra, PhD, Andrew S Kraft, MD

Blood (2016) 128 (22): 2742.

https://doi.org/10.1182/blood.V128.22.2742.2742

Published: 2016

Journal Articles

Pomalidomide Plus Dexamethasone (Pd) in the Treatment of Asian Patients with Relapsed/Refractory Myeloma (RRMM) Who Are Previously Treated with Bortezomib and Refractory to Lenalidomide - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Wee J Chng, MD MRCP, FRCPATH, PhD, Kihyun Kim, MD PhD, Jeffrey Huang, Chor Sang Chim, MBChB, Hiroshi Kosugi, MD PhD, Naoki Takezako, MD PhD, Junichi Sakamoto, MD PhD, Sathish Kumar Gopalakrishnan, Yuan Wei, Ling Ying Zhuo, Je-Jung Lee, Sung-Soo Yoon, MD PhD, Jin Seok Kim, MD PhD, Chang-Ki Min, Jae-Hoon Lee, Brian G M Durie

Blood (2016) 128 (22): 2130.

https://doi.org/10.1182/blood.V128.22.2130.2130

Published: 2016

Journal Articles

Time from Diagnosis to Initiation of Curative Chemotherapy Affects Outcomes in DLBCL - Data from a Large Asian Cohort

Colin Phipps, MBBS, MRCP, FRCPath, Yuh Shan Lee, MBBS, MRCP, FRCPath, Chandramouli Nagarajan, MBBS, MD MRCP, Yunxin Chen, MBBS, MRCP, FRCPath, Allan ZK Goh, Lay Poh Khoo, BSc, Kevin Tay, MD, Miriam Tao, MD, Richard Quek, Tiffany Tang, MD, Mohamad Farid, MD, Soon Thye Lim, MBBS, MRCP, Sathish Kumar Gopalakrishnan, FRCPath, Nicholas F Grigoropoulos, MRCP, FRCPath, Yvonne Loh, MBBS, MRCP, Daryl Tan, MBBS, MRCP, William YK Hwang, MBBS, MRCP, FRCP, Yeow Tee Goh, MD

Blood (2016) 128 (22): 1871.

https://doi.org/10.1182/blood.V128.22.1871.1871

Published: 2016

Journal Articles

Bortezomib Based Induction Is Superior to Thalidomide Based Induction in Reducing Early Relapses Following Upfront HDM: an Analysis By the Asian Myeloma Working Group

Sathish Kumar Gopalakrishnan, FRCPath, Shin-Yeu Ong, MD MRCP, MSE, Seok Jin Kim, Hae Su Kim, MD, Ji Yun Lee, Sung Hee Lim, Yunxin Chen, MBBS, MRCP, FRCPath, Sanjay De Mel, BSc, FRCPath, MRCP,, Melissa G. Ooi, Shilpa Surendran, MBBS, Adeline Lin, Daryl Tan, MBBS, MRCP, Brian G M Durie, Wee Joo Chng, MB ChB, MRCP, PhD, Kihyun Kim, MD PhD

Blood (2016) 128 (22): 4650.

https://doi.org/10.1182/blood.V128.22.4650.4650

Published: 2016

Journal Articles

Vinorelbine-Cyclophosphamide Compared to Cyclophosphamide in Peripheral Blood Stem Cell Mobilization for Multiple Myeloma

Sanjay De Mel, BSc,FRCPath,MRCP,, Yunxin Chen, MBBS,MRCP,, Adeline Lin, BSc, Eng Soo Yap, MBBS, Teck Guan Soh, Joanna Mah, Melissa G. Ooi, Sathish Kumar Gopalakrishnan, Lara Kristina Sioco Donato, Nurul Aidah Abdul Halim, Wee-Joo Chng, MB, ChB, PhD, lip Kun Tan

Blood (2015) 126 (23): 3103.

https://doi.org/10.1182/blood.V126.23.3103.3103

Published: 2015

Journal Articles

Impact of Post-Remission Consolidation Modalities in the Clinical Outcomes of Acute Myeloid Leukemia Patients in First Remission - Is There a Role for Autologous Hematopoietic Stem Cell Transplant?

May Anne Cheong, MBBS, MRCP, Gee Chuan Wong, MBBS, MRCP, FRCP, William YK Hwang, MBBS, MRCP, FRCP, Ho YL Aloysius, MBBS, MRCP, FRCPath, Yeh Ching Linn, MBBS, MRCP, Yeow-Tee YT Goh, MD, Yvonne Loh, MBBS, MRCP, Sathish Kumar, MBBS, MRCP, FRCPath, Colin Phipps, MBBS, MRCP, FRCPath, Zhentang Lao, MBBS, MRCP

Blood (2015) 126 (23): 3184.

https://doi.org/10.1182/blood.V126.23.3184.3184

Published: 2015

Journal Articles

Targeted Modifications in Adeno-Associated Virus Serotype (AAV)- 8 Capsid Improves Its Hepatic Gene Transfer Efficiency in Vivo

Dwaipayan Sen, Nishanth Gabriel, Sathish Kumar Yesupatham, Rekha Samuel, Rupali A Gadkari, G Sudha, N Srinivasan, Alok Srivastava, MD, Giridhara Rao Jayandharan

Blood (2012) 120 (21): 2045.

https://doi.org/10.1182/blood.V120.21.2045.2045

Published: 2012

Journal Articles

Role of mTOR Signaling in Erythropoiesis

Sathish Kumar Mungamuri, Saghi Ghaffari, MD, PhD

Blood (2008) 112 (11): 3870.

https://doi.org/10.1182/blood.V112.11.3870.3870

Published: 2008

Journal Articles

Oxidative Stress-Mediated Activation of AKT/mTOR Signaling Pathway Leads to Myeloproliferative Syndrome in FoxO3 Null Mice: A Role for Lnk Adaptor Protein

Safak Yalcin, Sathish Kumar Mungamuri, Dragan Marinkovic, Xin Zhang, Wei Tong, PhD, Dana Cullen, Saghi Ghaffari, MD, PhD

Blood (2008) 112 (11): 509.

https://doi.org/10.1182/blood.V112.11.509.509

Published: 2008

NARROW

Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM

A Comparison between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database

Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging

Therapeutic Targeting of PIM Protein Kinases in a Subset of T-Cell Acute Lymphoblastic Leukemia

Pomalidomide Plus Dexamethasone (Pd) in the Treatment of Asian Patients with Relapsed/Refractory Myeloma (RRMM) Who Are Previously Treated with Bortezomib and Refractory to Lenalidomide - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Time from Diagnosis to Initiation of Curative Chemotherapy Affects Outcomes in DLBCL - Data from a Large Asian Cohort

Bortezomib Based Induction Is Superior to Thalidomide Based Induction in Reducing Early Relapses Following Upfront HDM: an Analysis By the Asian Myeloma Working Group

Vinorelbine-Cyclophosphamide Compared to Cyclophosphamide in Peripheral Blood Stem Cell Mobilization for Multiple Myeloma

Impact of Post-Remission Consolidation Modalities in the Clinical Outcomes of Acute Myeloid Leukemia Patients in First Remission - Is There a Role for Autologous Hematopoietic Stem Cell Transplant?

Targeted Modifications in Adeno-Associated Virus Serotype (AAV)- 8 Capsid Improves Its Hepatic Gene Transfer Efficiency in Vivo

Role of mTOR Signaling in Erythropoiesis

Oxidative Stress-Mediated Activation of AKT/mTOR Signaling Pathway Leads to Myeloproliferative Syndrome in FoxO3 Null Mice: A Role for Lnk Adaptor Protein

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only